RE:RE:RE:RE:Gud news...schocor wrote: I doubt the 1.5% price DECLINE today has much - if anything - to do with the releasing a new drug yesterday. I had look at this drug from the IBS perspective and it is a decent one. They are thinking $600m a year at peak in the US so I am modelling $50-60M in Canada which is pretty decent. If they can find other used for this (hypertension) that is where the gravy is.
Also the 10% rule of thumb doesnt really work. Even less now with the new pricing rules on drugs in Canada.